2018
DOI: 10.3892/ol.2018.8097
|View full text |Cite
|
Sign up to set email alerts
|

Expression of cancer-associated fibroblast markers in advanced colorectal cancer

Abstract: Colorectal cancer is one of the most common causes of mortality from cancer worldwide. Previous studies have demonstrated that cancer-associated fibroblasts (CAFs) promote neoangiogenesis and tumor growth for various tumors. The present study analyzed CAF markers, including α-smooth muscle actin (α-SMA), collagen I, platelet-derived growth factor receptor-β (PDGFR-β), and D2-40 (antibody recognizing podoplanin), and vessel markers, including cluster of differentiation (CD)31 and CD34, for 121 advanced colorect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
37
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(42 citation statements)
references
References 21 publications
1
37
0
Order By: Relevance
“…To this end SW620 cells expressing luciferase were orthotopically injected alone or together with fibroblasts in the caecum of immunocompromised (NSG) mice. Fibroblasts and tumor cells were mixed and injected at a 1:1 ratio which is a realistic approximation of the average Cancer Associated Fibroblasts (CAF): epithelial cell ratio observed in human CRC, considering variability observed in different CRC subtypes, stages and intertumoral heterogeneity (Henry et al, 2007 ; Isella et al, 2015 ; Nishishita et al, 2018 ). Fibroblasts co-injected with tumor cells did not impact primary tumor growth (Supplementary Figure S3 ).…”
Section: Resultsmentioning
confidence: 99%
“…To this end SW620 cells expressing luciferase were orthotopically injected alone or together with fibroblasts in the caecum of immunocompromised (NSG) mice. Fibroblasts and tumor cells were mixed and injected at a 1:1 ratio which is a realistic approximation of the average Cancer Associated Fibroblasts (CAF): epithelial cell ratio observed in human CRC, considering variability observed in different CRC subtypes, stages and intertumoral heterogeneity (Henry et al, 2007 ; Isella et al, 2015 ; Nishishita et al, 2018 ). Fibroblasts co-injected with tumor cells did not impact primary tumor growth (Supplementary Figure S3 ).…”
Section: Resultsmentioning
confidence: 99%
“…Cancer-associated fibroblasts (CAFs) in the immediate vicinity of cancer cells play an important role in tumorigenesis in various physicochemical ways by reducing apoptosis and improving the proliferation, migration and viability of cancer cells [58,59]. CAFs residing in TME are heterogeneous cells with different origins, different functions (pro or anti-tumor activities) and different surface markers such as alpha-smooth muscle actin (α-SMA), myosin light chain 9 (MYL9), myosin light chain kinase (MYLK), matrix metalloproteinase 2 (MMP2), decorin (DCN) and collagen type I alpha 2 (COL1A2) [60][61][62][63].…”
Section: Cancer-associated Fibroblast (Cafs)mentioning
confidence: 99%
“…Not exclusive to fibroblasts. 91,92 No which seem to be sensitive to factors such as CAF subtype (αSMA, FAP) or hypoxia (αSMA, POSTN). Another strength of the PDGFRs is that, unlike αSMA, they are surface-bound markers, allowing for flow cytometry-based sorting of viable fibroblast populations for long-term assays and cultures.…”
Section: Fibroblast Markersmentioning
confidence: 99%